These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25591247)

  • 21. [Severe hepatitis induced by chemotherapy with antitubercular agents in childhood. 2 cases].
    Chapoy P; Ferracci JP; Mattei JF; Granjon B; Louchet E
    Pediatrie; 1978; 3(7):637-45. PubMed ID: 740454
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug-induced liver disease.
    Keeling PW; Thompson RP
    Br Med J; 1979 Apr; 1(6169):990-3. PubMed ID: 435958
    [No Abstract]   [Full Text] [Related]  

  • 23. [Autoimmune mechanisms and post-anesthetic hepatitis].
    Duheille J; Montagne P
    Ann Anesthesiol Fr; 1976; 17(3):327-34. PubMed ID: 1078522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Grave and unusual results of the use of some psychopharmacological agents].
    Quaranta A
    Recenti Prog Med; 1974 Sep; 57(3):240-68. PubMed ID: 4153212
    [No Abstract]   [Full Text] [Related]  

  • 25. [Possibility of differentiating viral and drug-induced hepatitis in tuberculous patients].
    Fomin DKh; Gerasun BA; Gutarevich EA
    Sov Med; 1971 Jun; 34(6):74-8. PubMed ID: 5115455
    [No Abstract]   [Full Text] [Related]  

  • 26. Risk factors for anti tuberculous drugs induced hepatitis: a prospective survey from a chest clinic in a general hospital.
    Fauzi AR; Shah A; Rathor MY; Satwi S
    Med J Malaysia; 2004 Mar; 59(1):72-7. PubMed ID: 15535339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regarding "Management of antitubercular drug-induced hepatotoxicity and therapy reintroduction strategy in a TB clinic of Nepal".
    Anupa KC; Bista D
    Kathmandu Univ Med J (KUMJ); 2005; 3(3):310. PubMed ID: 18661667
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis due to anti-tuberculous drugs.
    Aggarwal NP
    Indian J Chest Dis Allied Sci; 1992; 34(4):231-2. PubMed ID: 1302758
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug-induced hepatitis in pulmonary tuberculosis patients].
    Koriakin VIa; Sokolova GB; Ziia AV; Zeliger LR; Glik MS
    Vrach Delo; 1984 May; (5):60-2. PubMed ID: 6741089
    [No Abstract]   [Full Text] [Related]  

  • 30. Isoniazid-related fatal hepatitis.
    Salpeter SR
    West J Med; 1996 Nov; 165(5):323. PubMed ID: 8993215
    [No Abstract]   [Full Text] [Related]  

  • 31. Antituberculous therapy and acute liver failure.
    Caplin M; Thompson N; Hamilton M; McIntyre N; Burroughs A
    Lancet; 1995 May; 345(8958):1171. PubMed ID: 7786346
    [No Abstract]   [Full Text] [Related]  

  • 32. [Characteristics of drug-induced hepatitis in patients with tuberculosis].
    Vil'derman AM
    Probl Tuberk; 1972; 50(5):59-63. PubMed ID: 4112966
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatic toxicity of antitubercular agents: role of the HBS antigen carriers].
    Flammang d'Ortho MP; Altman C; Cadranel J; Grange JD; Mayaud C
    Rev Pneumol Clin; 1990; 46(3):128-9. PubMed ID: 2237147
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pathogenesis and treatment strategies of drug-induced liver injury].
    Chen CW
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):726-8. PubMed ID: 24433798
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe acute hepatitis associated with morphazinamide therapy.
    Zavaglia C; Mondazzi L; Fesce E; Iamoni G; Lanzani F; Ideo G
    J Hepatol; 1996 Dec; 25(6):1001. PubMed ID: 9007735
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hepatitis of prolonged development induced by various tuberculostatic drugs].
    Brincourt J; Teyssier L
    Rev Tuberc Pneumol (Paris); 1968; 32(6):831-8. PubMed ID: 5743631
    [No Abstract]   [Full Text] [Related]  

  • 37. Antituberculous therapy and acute liver function.
    FitzGerald JM
    Lancet; 1995 May; 345(8958):1172. PubMed ID: 7723558
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hepatic jaundice in patients with pulmonary tuberculosis treated with various combinations of antitubercular drugs].
    Kubiak Z
    Gruzlica; 1968 Oct; 36(11):1133-5. PubMed ID: 5710701
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neuroleptic treatment of children and Australia antigen carrier state].
    Bautsch A; Zajaczkowski J; Zyblikiewicz D
    Psychiatr Pol; 1976; 10(4):433-4. PubMed ID: 981418
    [No Abstract]   [Full Text] [Related]  

  • 40. [Liver and antitubercular drug therapy].
    Viroglio AL; Piñeyro JO; Acosta A; Munaro N; Escarguel Malbrán J; Pérez JA
    Rev Fac Cienc Med Cordoba; 1974; 32(1):19-36. PubMed ID: 4458009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.